Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04731870
Status:
COMPLETED
Last Update Posted:
2023-07-27
First Post:
2021-01-27
Brief Title:
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
Sponsor:
East Carolina University
Organization:
East Carolina University
Study Overview
Official Title:
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines Among a Cross-section of US Healthcare Providers and Key At-risk Subgroups in the Rural South
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The COVID-19 pandemic has highlighted deleterious US health inequities Specifically African Americans Latinos and Native Americans have and continue to shoulder a greater burden of COVID-19 infections and deaths in the US In addition to existing racial and ethnic disparities are rural health and regional disparities Given the disproportionate impact of disease in US communities of color and also in rural and southern regions of the US there is no doubt that these at-risk subgroups will continue to experience higher rates of coronavirus-related mortality as well as other long-term health outcomes as compared to other US populations
It is unknown how healthcare providers and other key at-risk subgroups within the US will receive COVID-19 vaccines For success in immunizations the US will need to reach their most at-risk and vulnerable populations In addition to at-risk populations a successful immunization strategy will involve engaging providers to support clear consistent and strong vaccine recommendation It is critical to build vaccine trust confidence and overall acceptance of COVID-19 vaccines among healthcare providers and key at-risk subgroups especially given the accelerated production timeline of these vaccines Likewise tailored vaccine messaging for key subgroups is vital in achieving vaccine confidence and trust
The proposed study will explore perceptions confidence trust and uptake of potential COVID-19 vaccines among healthcare providers nurses and doctors and key at-risk population subgroups minority populations living in the rural south and will develop and test vaccine messaging that boosts vaccine confidence and trust among these key at-risk subgroups
It is unknown how healthcare providers and other key at-risk subgroups within the US will receive COVID-19 vaccines For success in immunizations the US will need to reach their most at-risk and vulnerable populations In addition to at-risk populations a successful immunization strategy will involve engaging providers to support clear consistent and strong vaccine recommendation It is critical to build vaccine trust confidence and overall acceptance of COVID-19 vaccines among healthcare providers and key at-risk subgroups especially given the accelerated production timeline of these vaccines Likewise tailored vaccine messaging for key subgroups is vital in achieving vaccine confidence and trust
The proposed study will explore perceptions confidence trust and uptake of potential COVID-19 vaccines among healthcare providers nurses and doctors and key at-risk population subgroups minority populations living in the rural south and will develop and test vaccine messaging that boosts vaccine confidence and trust among these key at-risk subgroups
Detailed Description:
Study objectives are as follows Objective 1 To assess COVID-19 perceptions COVID-19 vaccine confidence projected vaccine recommendation practices and trust in the health system and public health authorities among a cross-section of healthcare providers in the US nurses and physicians Objective 2 To assess COVID-19 perceptions COVID-19 vaccine confidence projected vaccine uptake and trust in the health system in healthcare providers and in public health authorities among key at-risk subgroups in the US minority populations living in the rural south and Objective 3 To develop tailor and test COVID-19 vaccine messaging to boost vaccine confidence and trust and COVID-19 preventive behavior among at-risk subgroups in the US minority populations living in the rural south Perceptions confidence uptake and trust in potential COVID-19 vaccines will be assessed among four identified and distinct groups via a quantitative and electronic survey and qualitative focus groups with key at-risk subgroups will be utilized to develop tailor and test COVID-19 vaccine messaging for at-risk subgroups
This study will 1 provide important national-level data regarding healthcare provider vaccine perceptions confidence trust and projected vaccine recommendation practices for COVID-19 2 ascertain vaccine perceptions confidence trust and projected uptake of potential COVID-19 vaccines among at-risk populations in the US and 3 develop tailored messaging for at-risk populations that can be used to boost vaccine confidence and trust and preventive behaviors among these high-risk groups in the coming years This study will help to inform a larger coordinated national promotion strategy and campaign that can work to effectively communicate with the public about potential COVID-19 vaccines
This study will 1 provide important national-level data regarding healthcare provider vaccine perceptions confidence trust and projected vaccine recommendation practices for COVID-19 2 ascertain vaccine perceptions confidence trust and projected uptake of potential COVID-19 vaccines among at-risk populations in the US and 3 develop tailored messaging for at-risk populations that can be used to boost vaccine confidence and trust and preventive behaviors among these high-risk groups in the coming years This study will help to inform a larger coordinated national promotion strategy and campaign that can work to effectively communicate with the public about potential COVID-19 vaccines
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None